MoneyWorks4Me

Kabra Drugs informs about outcome of EGM

02 Jan 2025 Evaluate
Pursuant to Regulation 30 read with Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), Kabra Drugs has enclosed proceedings of the Extra Ordinary General Meeting of the Company held on Thursday, January 02, 2025 at 11.00 AM at the registered office of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..